Hemab Therapeutics Holdings, Inc. IPO
FireStrike is tracking the Hemab Therapeutics Holdings, Inc. IPO. Analysis and commentary will appear here as filings, roadshow details, and pricing information become available. Subscribe to the daily brief to get updates the morning they happen.
Frequently asked questions
When is Hemab Therapeutics Holdings, Inc. going public?
Hemab Therapeutics Holdings, Inc. has not yet announced an IPO date or filed a registration statement with the SEC. FireStrike will update this page when official filings or announcements are made.
What is Hemab Therapeutics Holdings, Inc.'s IPO valuation?
The estimated offering value is $100M. Final valuation will be determined at pricing.
What exchange will Hemab Therapeutics Holdings, Inc. list on?
No exchange has been officially announced for the Hemab Therapeutics Holdings, Inc. IPO.
Has Hemab Therapeutics Holdings, Inc. filed an S-1 with the SEC?
No. As of the most recent data, Hemab Therapeutics Holdings, Inc. has not filed a Form S-1 or other registration statement with the SEC.